EUVIMEDEUVIMED entdecken
Open Access

Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis

Nathalie E Marchand, May Y Choi, Emily G Oakes, Nancy R Cook, Emma Stevens, Natalya Gomelskaya, Gregory Kotler, JoAnn E Manson, Jessica Lasky-Su, Samia Mora, I-Min Lee, Raju Tatituri und 1 weitere

Prostaglandins, Leukotrienes and Essential Fatty Acids · 2023-03 · 190 · 102542

DOI: 10.1016/j.plefa.2023.102542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2023-03. Verfasst von Nathalie E Marchand und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. E…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Arthritis, Rheumatoid. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Little is known about the effects of over-the-counter fish oil (FO) supplements on circulating omega-3 polyunsaturated fatty acid (n-3 PUFA)-derived specialized pro-resolving mediators (SPMs), nor about whether having a chronic inflammatory disease such as rheumatoid arthritis (RA) influences SPM levels. We investigated associations between over-the-counter n-3 PUFA FO supplementation and circulating SPMs among patients with vs. without RA. METHODS: We studied 104 participants: 26 with RA taking FO matched by age and sex to 26 with RA not taking FO, 26 without RA taking FO, and 26 without RA not taking FO. Targeted-liquid chromatography-tandem mass spectroscopy was performed on patient plasma to identify and quantify 27 lipid mediators (including eicosanoids and SPMs). We performed t-tests and then multivariable linear regression analyses to assess whether having RA or taking FO supplements was associated with circulating lipid mediator concentrations, adjusting for age, race, sex, smoking, body mass index, and current medication use (statins, prednisone and immunomodulators among RA cases only). We tested for interactions between FO supplementation and RA status. We also conducted Spearman's correlations between EPA, DHA, and ARA and their downstream metabolites. RESULTS: Among patients who were taking FO compared to those who were not, in multivariable- adjusted analyses, SPM substrates EPA and DHA were both elevated as were several of their pro-resolving bioactive products, including 15- and 18-HEPE from EPA, and 14- and 17-HDHA from DHA, which are substrates for specific SPMs. While E-series and D-series resolvins were present and identified, we did not find statistical elevations of other SPMs. Results were similar among patients with RA and patients without RA, taking vs. not taking FO supplementation (no formal statistical interaction observed). There was a strong positive correlation between EPA and DHA and their immediate downstream SPM precursors (18-HEPE and15-HEPE from EPA; 17-HDHA and 14-HDHA from DHA) among all patients. CONCLUSION: Patients taking FO supplements, regardless of RA status, not only had higher blood levels of EPA and DHA, but also of their enzymatic products 18-HEPE (E-series resolvin precursors), 15-HEPE and 17-HDHA (D-series resolvin and protectin precursors). Patients with RA, an inflammatory autoimmune disease, may be able to augment some SPM precursor reserves, similarly to matched controls without RA, by taking oral FO supplements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3Arthritis, RheumatoidHumansFish OilsDocosahexaenoic AcidsEicosapentaenoic AcidDietary SupplementsFatty Acids

Stichwörter der Autor:innen

DHAEPAOmega-3 fatty acidRheumatoid arthritisSpecialized pro-resolving mediatorfish oil

Substanzen

Fish OilsDocosahexaenoic AcidsFatty Acids, Omega-3Eicosapentaenoic AcidFatty Acids

Autor:innen und Institutionen

  • Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: nem083@mail.harvard.edu.
  • Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Rheumatology, Cumming School of Medicine, University of Cal…
  • Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Systems Genetics and Genomics Unit, Channing Division of Network Medicine Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical Schoo…

Förderung

  • NHLBI NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Marchand, N. E., Choi, M. Y., Oakes, E. G., Cook, N. R., Stevens, E., Gomelskaya, N., Kotler, G., Manson, J. E., Lasky-Su, J., Mora, S., Lee, I. M., Tatituri, R., & Costenbader, K. H. (2023). Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids, 190, 102542. https://doi.org/10.1016/j.plefa.2023.102542

Vancouver

Marchand NE, Choi MY, Oakes EG, Cook NR, Stevens E, Gomelskaya N, et al. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2023;190:102542. doi:10.1016/j.plefa.2023.102542

BibTeX
@article{Marchand2023,
  author = {Marchand, Nathalie E and Choi, May Y and Oakes, Emily G and Cook, Nancy R and Stevens, Emma and Gomelskaya, Natalya and Kotler, Gregory and Manson, JoAnn E and Lasky-Su, Jessica and Mora, Samia and Lee, I-Min and Tatituri, Raju and Costenbader, Karen H},
  title = {Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis},
  journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
  year = {2023},
  volume = {190},
  pages = {102542},
  doi = {10.1016/j.plefa.2023.102542}
}
Kostenlos starten →